Skip to Content

Guided Therapeutics Inc GTHP

Morningstar Rating
$0.14 +0.03 (26.32%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GTHP is trading at a 94% premium.
Price
$0.14
Fair Value
$8.38
Uncertainty
Extreme
1-Star Price
$9.60
5-Star Price
$3.53
Economic Moat
Xmrf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GTHP is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.11
Day Range
$0.140.14
52-Week Range
$0.060.30
Bid/Ask
$0.10 / $0.14
Market Cap
$7.74 Mil
Volume/Avg
3,662 / 27,127

Key Statistics

Price/Earnings (Normalized)
Price/Sales
88.96
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
4

Valuation

Metric
GTHP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
88.96
Price/Cash Flow
Price/Earnings
GTHP

Financial Strength

Metric
GTHP
Quick Ratio
0.08
Current Ratio
0.23
Interest Coverage
−9.98
Quick Ratio
GTHP

Profitability

Metric
GTHP
Return on Assets (Normalized)
−93.77%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
GTHP
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
GjnzhqtfMvwxsgz$180.8 Bil
Stryker Corp
SYK
BxljxsmbBcrfk$130.2 Bil
Boston Scientific Corp
BSX
NpdpwxgylMlnrtqq$115.5 Bil
Medtronic PLC
MDT
KhxybnnjfYtdppt$101.8 Bil
Edwards Lifesciences Corp
EW
ZnvnnnyrgsVphbvz$52.5 Bil
DexCom Inc
DXCM
BlghtpsfzJdwp$44.4 Bil
Koninklijke Philips NV ADR
PHG
XvxkprzsJyhlq$24.5 Bil
Steris PLC
STE
ZpsthljgVhjfrnq$22.9 Bil
Zimmer Biomet Holdings Inc
ZBH
NhcfvmhpmrYmvf$22.6 Bil
Align Technology Inc
ALGN
YvmmqzjhqSbtyzkl$18.9 Bil

Sponsor Center